Terms: = Sarcomas AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Diagnosis
16 results:
1. [Primary cardiac synovial sarcoma: a clinicopathological analysis of five cases].
Liu XH; Liu YH; Li Z; Zhang MH
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):358-363. PubMed ID: 38556819
[No Abstract] [Full Text] [Related]
2. [Primary synovial sarcoma of lung: a clinicopathological analysis of 12 cases].
Zhang XW; Wei JG; Sun JP; Xu ZG; Cheng Q; Zhang L; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1120-1125. PubMed ID: 37899317
[No Abstract] [Full Text] [Related]
3. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
[TBL] [Abstract] [Full Text] [Related]
4. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report.
Minoshima A; Sugita S; Segawa K; Aoyama T; Ito M; Daimon F; Takenami T; Kido T; Moriya J; Nishikiori H; Hasegawa T
Diagn Cytopathol; 2023 May; 51(5):E149-E154. PubMed ID: 36772934
[TBL] [Abstract] [Full Text] [Related]
5. The value of sox2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
[TBL] [Abstract] [Full Text] [Related]
6. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract] [Full Text] [Related]
7. SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C; Le Loarer F
Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
[TBL] [Abstract] [Full Text] [Related]
8. EWS promotes cell proliferation and inhibits cell apoptosis by regulating miR-199a-5p/sox2 axis in osteosarcoma.
He P; Ding J
Biotechnol Lett; 2020 Jul; 42(7):1263-1274. PubMed ID: 32236759
[TBL] [Abstract] [Full Text] [Related]
9. Cytopathological Features of
Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
[No Abstract] [Full Text] [Related]
10. Gene expression and immunohistochemical analyses identify sox2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.
Sannino G; Marchetto A; Ranft A; Jabar S; Zacherl C; Alba-Rubio R; Stein S; Wehweck FS; Kiran MM; Hölting TLB; Musa J; Romero-Pérez L; Cidre-Aranaz F; Knott MML; Li J; Jürgens H; Sastre A; Alonso J; Da Silveira W; Hardiman G; Gerke JS; Orth MF; Hartmann W; Kirchner T; Ohmura S; Dirksen U; Grünewald TGP
EBioMedicine; 2019 Sep; 47():156-162. PubMed ID: 31427232
[TBL] [Abstract] [Full Text] [Related]
11. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract] [Full Text] [Related]
12. Multifocal Synchronous Upper Urinary Tract Carcinosarcoma (Sarcomatoid Carcinoma) With Rhabdomyoblastic Differentiation.
Takemura K; Motoi T; Tonooka A; Funata N; Nakanishi Y; Kataoka M; Ito M; Sakamoto K; Suzuki H; Tobisu KI; Koga F
Int J Surg Pathol; 2019 Aug; 27(5):547-552. PubMed ID: 30767589
[TBL] [Abstract] [Full Text] [Related]
13. SMARCA4-deficient Thoracic sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
[TBL] [Abstract] [Full Text] [Related]
14. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract] [Full Text] [Related]
15. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F
Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384
[TBL] [Abstract] [Full Text] [Related]
16. miR-126 functions as a tumor suppressor in osteosarcoma by targeting sox2.
Yang C; Hou C; Zhang H; Wang D; Ma Y; Zhang Y; Xu X; Bi Z; Geng S
Int J Mol Sci; 2013 Dec; 15(1):423-37. PubMed ID: 24384842
[TBL] [Abstract] [Full Text] [Related]
